| Identification | Back Directory | [Name]
Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, phenylcarbamate (ester), (3aR,8aS)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) (9CI) | [CAS]
865795-23-9 | [Synonyms]
Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, phenylcarbamate (ester), (3aR,8aS)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) (9CI) | [Molecular Formula]
C24H29N3O8 | [MOL File]
865795-23-9.mol | [Molecular Weight]
487.51 |
| Hazard Information | Back Directory | [Uses]
Buntanetap (L-Tartrate) is an orally administered small molecule inhibitor of several neurotoxic proteins. Buntanetap reduces amyloid precursor protein (APP) production by blocking its mRNA translation[1]. | [References]
[1] Gubar M , et al. Buntanetap: Breakthrough in Treatment of Alzheimer's and Parkinson's. BioPharma Media. 2023, 11. |
|
|